Story
Vallourec Shares Surge on Major Contract for Petrobras Offshore Project

Summary
The French tube manufacturer's stock rose sharply after it secured a significant contract via Subsea7 to supply line pipes for Petrobras's Sepia 2 offshore project, bolstering its order book.
Shares in Vallourec S.A. (VLLP), a French specialist in seamless tubes, surged 5.8% to €19.78 during Wednesday's session after the company announced a major contract win for a deepwater project in Brazil.
Brazilian Offshore Contract Secured
The contract was awarded by Subsea7 for Petrobras’s Sepia 2 pre-salt offshore development in the Santos Basin. In a press release issued before the Paris market opened, Vallourec confirmed it will supply the full scope of carbon steel line pipes for the project.
Key details of the supply agreement include:
- Approximately 130 kilometers of subsea risers and flowlines.
- Pipes will feature an external thermal insulation coating.
- The company highlighted the contract as a single integrated offer demonstrating its end-to-end capabilities.
Market Impact and Outlook
AdThe announcement provided a significant boost to investor sentiment, which had been cautious following softer-than-expected Q2 2026 results. This new order adds meaningful weight to Vallourec's order book and serves as a tangible near-term catalyst for the stock.
The contract win builds on recent commercial momentum, including a supply agreement with Saudi Aramco announced earlier this month. Analyst consensus for Vallourec stock remains at "Buy," with an average 12-month price target of approximately €23.50, according to the source material.
Broader Context
Vallourec's gains outpaced the broader market, with France’s benchmark CAC 40 index trading only modestly higher by around 0.3%. The contract provides a strong, company-specific driver in a cautious European market environment shaped by recent central bank policy decisions.
Read next
More on Stocks
Large Bullish Options Trade Bets on BioMarin Stock Reaching $100 by April 2027
A significant options trade on BioMarin Pharmaceutical suggests a trader is betting on the stock to rise more than 37% by April 2027, a move supported by unusual volatility signals.

GlobalFoundries Stock Rallies on US-Japan Fab Report, Marvell AI Deal
Shares of the semiconductor manufacturer jumped after a report detailed negotiations for a multi-billion dollar U.S. factory backed by Japan, alongside a new manufacturing agreement with Marvell for AI components.

Lyft Stock Slips After Guggenheim Downgrade on Growth Concerns
Guggenheim downgraded Lyft to Neutral from Buy and cut its price target to $16, citing a reduced growth forecast and uncertainty from an upcoming CFO change.

SpaceX Considers Buying Data From Failed Startups for AI Development, Report Says
Elon Musk's SpaceX is reportedly holding internal discussions to acquire customer and operational data from struggling or defunct startups, a move aimed at sourcing affordable data to train its artificial intelligence models.